A study led by Manuel Vázquez Carrera, group leader at the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Centre (CIBERDEM) at the University of Barcelona, reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic dysfunction-associated steatotic liver disease).
Enveda raises $130m to advance AI-driven plant based drug development – Pharmaceutical Technology
Enveda draws its foundational principles from the established connection between natural compounds and medicines. Credit: Natapon khantiwong via Shutterstock. Artificial Intelligence (AI)-driven biotech Enveda Biosciences
November 22, 2024